Medigus Signed a Binding Letter of Intent with Polyrizon for an Investment in and Joint Commercialization of Biological Gels for Protecting Patients against COVID-19 and Other Biological Threats
About Medigus Ltd.
- NASDAQ: $MDGS
- Notified: $1.52
- 07:00 EDT
